Q&A: Owkin’s five-year Sanofi deal bets on ‘purpose-built’ AI agents
Image from Owkin Over the past two years, software engineering has handed a growing share of its routine…
Sanofi deepens its Owkin bet with a five-year deal to build bespoke drug-development agents
A 3D rendering of a biological cell from the company’s homepage, where it animates to reveal layers of…